ORIGINAL ARTICLE
Association of tumor mutation burden and epidermal growth factor receptor inhibitor history with survival in patients with metastatic stage III/IV non-small-cell lung cancer: A retrospective study
Yan LanI, Shuo ZhouII, Weihong FengIII, Ying QiaoI, Xueming DuIII,
, Fenge LiIII,IV,
Corresponding author
Corresponding author
I Department of Oncology, Chifeng Songshan Hospital, Mongolia, China
II Department of Nuclear Medicine, Provincial Clinical Hospital of Fujian Medical University, Fuzhou, China
III Department of Oncology, Tianjin Beichen Hospital, Tianjin, China
IV Department of Melanoma, University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA
Read
1008
Timeswas read the article
341
Total PDF
667
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2024 July | 38 | 20 | 58 |
| 2024 June | 37 | 12 | 49 |
| 2024 May | 40 | 29 | 69 |
| 2024 April | 66 | 33 | 99 |
| 2024 March | 48 | 19 | 67 |
| 2024 February | 31 | 19 | 50 |
| 2024 January | 20 | 31 | 51 |
| 2023 December | 27 | 15 | 42 |
| 2023 November | 24 | 31 | 55 |
| 2023 October | 22 | 43 | 65 |
| 2023 September | 20 | 29 | 49 |
| 2023 August | 32 | 7 | 39 |
| 2023 July | 27 | 24 | 51 |
| 2023 June | 27 | 4 | 31 |
| 2023 May | 46 | 1 | 47 |
| 2023 April | 53 | 8 | 61 |
| 2023 March | 35 | 4 | 39 |
| 2023 February | 26 | 3 | 29 |
| 2023 January | 26 | 3 | 29 |
| 2022 December | 14 | 4 | 18 |
| 2022 November | 8 | 2 | 10 |
Show all